Sunzen Biotech Berhad reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was MYR 23.89 million compared to MYR 17.45 million a year ago. Net income was MYR 0.951 million compared to MYR 0.071 million a year ago. Basic earnings per share from continuing operations was MYR 0.0014 compared to MYR 0.0001 a year ago. Diluted earnings per share from continuing operations was MYR 0.0012 compared to MYR 0.0001 a year ago.
For the nine months, sales was MYR 80.07 million compared to MYR 61.45 million a year ago. Net income was MYR 2.5 million compared to MYR 0.031 million a year ago. Basic earnings per share from continuing operations was MYR 0.0036 compared to MYR 0.0001 a year ago. Diluted earnings per share from continuing operations was MYR 0.0032 compared to MYR 0.00005 a year ago.